The efficacy of memantine , a noncompetitive glutamate N-methyl-D-aspartate ( NMDA ) - receptor blocker used for the treatment of moderate to severe Alzheimer 's disease , was compared with that of escitalopram , a selective serotonin reuptake inhibitor antidepressant .
